Groundbreaking discoveries regarding the onset of cholera are paving the way for a future, fast-acting antidote for cholera epidemics, according to research published in the journals PLOS Pathogens and ACS Infectious Disease.
“This is not about a vaccine but rather a drinkable protection that can be distributed during an ongoing cholera epidemic to reduce its spread, a drink that blocks the cholera toxin so that it doesn’t reach the intestinal mucous membrane, where all the chaos otherwise gets under way,” says Ulf Yrlid, associate professor of immunology at Sahlgrenska Academy.
Those responsible for the studies are Ulf Yrlid along with colleagues in Gothenburg and a research team at the University of Texas Southwestern Medical Center in Dallas. To some extent, their discoveries run counter to earlier notions about the life-threatening disease.
Cholera is caused by a toxin released by bacteria, cholera toxin, which binds to the intestinal wall, causing massive fluid loss through diarrhea. The binding has long been believed to be dependent on a specific receptor in the intestine, GM1.
Other ways to become sick
Current research shows, however, that mice that completely lack GM1 also get diarrhea after drinking water containing cholera toxin. In addition, fluid loss could be prevented in human intestinal tissue exposed to cholera toxin by adding molecules that block binding to completely different receptors than GM1.
“The big takeaway for us is that we have shown that it’s not quite as simple as people have maintained for decades. GM1 is indeed a very powerful receptor in this context, but unlike the other receptors, there is very little of it in the human intestine,” says Ulf Yrlid.
According to the researchers, the results also offer the possibility of producing a drinkable antidote that can put both GM1 and other receptors out of play. This could complement other emergency initiatives in areas where sufficient vaccination protection is lacking.
Protection for unvaccinated people
“The problem with vaccines is that they work less well in developing countries due to malnutrition and poor health, especially when it comes to small children. This is not unique for cholera vaccine, but applies to the entire field of vaccination,” says Ulf Yrlid.
“If we could use molecules that bind effectively to the cholera toxin and thereby prevent the toxin from attaching to the intestine, we could then immediately reduce the spreading in an affected area, even if people are not vaccinated or don’t have sufficient protection. One advantage of the molecules we modify is they are sugar molecules that already are present in breast milk to a great extent and therefore are safe to drink,” he concludes.
The Latest on: Cholera
- Cholera kills hundreds, worsens DRC health woes on February 19, 2019 at 9:41 pm
KINSHASA, (CAJ News) – NO less than 71 people have died this year in the worst cholera outbreak afflicting the Democratic Republic of Congo (DRC) in over two decades. The deaths are from 2 705 ... […]
- How to block new antibiotic resistance gene on February 19, 2019 at 3:41 pm
A new antimicrobial-resistance gene, VCC-1, a beta-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera. Now, a team of Canadian researchers ... […]
- DRC Population Movement - Emergency Plan of Action Operation Update n° 3 (EPoA) DREF n° MDRCD023 on February 19, 2019 at 2:49 pm
According to the latest WHO and Ministry of Health (MoH) reports in DRC, the current trend of Cholera in the country has taken a new turn, with 2 new provinces upgraded to the epidemic status with ... […]
- Briefing: Haiti’s new crisis and the humanitarian risks on February 19, 2019 at 3:23 am
The last decade has been cruel to Haiti: one of the world’s deadliest ever earthquakes struck in 2010; cholera, brought in accidentally by UN peacekeepers, then ravaged the country for years afterward... […]
- Uganda: Cholera sickens dozens in Kampala area on February 18, 2019 at 4:05 pm
As of Feb. 10, 53 cholera cases, including three fatalities ave been reported across Kampala City and two other districts, Wakiso and Luwero. According to WHO, a number of public health actions ... […]
- Zimbabwe: Strive and Tsitsi Masiyiwa Avail $60 Million Towards Cholera Response in Zimbabwe on February 11, 2019 at 4:57 am
The family foundation of Econet founders Strive and Tsitsi Masiyiwa has committed an additional US$60 million towards the cholera response in Zimbabwe. The commitment comes on the back of an ... […]
- Press Release: Tsitsi And Strive Masiyiwa Donate A Further $60 Million To Eradicate Cholera on February 10, 2019 at 8:31 am
Last week Tsitsi and Strive Masiyiwa committed $100 million for rural entrepreneurship development in Zimbabwe. The couple has really stepped up their philanthropic efforts in the country and across A... […]
- Masiyiwas donate $60 m to fight cholera on February 9, 2019 at 7:10 pm
The family foundation of Econet founders Strive and Tsitsi Masiyiwa has committed an additional $60 million towards the cholera response in Zimbabwe. The commitment comes on the back of an initial $10 ... […]
- NASA Investment in Cholera Forecasts Helps Save Lives in Yemen on February 8, 2019 at 7:41 am
For the first time ever, measurements from NASA Earth-observing research satellites are being used to help combat a potential outbreak of life-threatening cholera. For the first time ever, measurement... […]
- Cholera: Zamfara agency constructs 35 boreholes on February 7, 2019 at 8:26 am
Alhaji Sani Yaro, the Programme Manager, Zamfara Rural Water Supply and Sanitation Agency (RUWASSA), says no fewer than 35 hand pump boreholes have been constructed in cholera affected communities in ... […]
via Google News and Bing News